Overcoming tumor necrosis factor-α resistance of human renal and ovarian carcinoma cells by combination treatment with buthionine sulfoximine and tumor necrosis factor-α. Role of tumor necrosis factor-α mRNA down-regulation in tumor cell sensitization
Open Access
- 1 February 1994
- Vol. 73 (3) , 730-737
- https://doi.org/10.1002/1097-0142(19940201)73:3<730::aid-cncr2820730338>3.0.co;2-x
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Overcoming cis-diamminedichloroplatinum (II) resistance of human ovarian tumor cells by combination treatment with cis-diamminedichloroplatinum (II) and tumor necrosis factor–alphaCancer, 1993
- Induction of Manganous Superoxide Dismutase by Tumor Necrosis Factor: Possible Protective MechanismScience, 1988
- A phase I trial of intravenously-administered recombinant tumor necrosis factor-alpha in cancer patients.Journal of Clinical Oncology, 1988
- Induction of tumor necrosis factor expression and resistance in a human breast tumor cell line.Proceedings of the National Academy of Sciences, 1987
- Recombinant Human Tumor Necrosis Factor-α: Effects on Proliferation of Normal and Transformed Cells in VitroScience, 1985
- Tumor Necrosis Factor (TNF)Science, 1985
- Molecular Cloning of the Complementary DNA for Human Tumor Necrosis FactorScience, 1985
- Cloning and expression in Escherichia coli of the gene for human tumour necrosis factorNature, 1985
- Human tumor necrosis factor produced by human B-cell lines: synergistic cytotoxic interaction with human interferon.Proceedings of the National Academy of Sciences, 1983
- An endotoxin-induced serum factor that causes necrosis of tumors.Proceedings of the National Academy of Sciences, 1975